HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring

HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient

AAIC 2023 Poster: A novel automated multiplex immunoassay for

YMJ :: Yonsei Medical Journal

Sensors, Free Full-Text

Antioxidants, Free Full-Text

NuraLogix researchers announce AI models that can predict Blood

Remote sensing of vital signs by medical radar time-series signal

HRX 22

Digital pathology with artificial intelligence analysis provides

PDF) The investigation of WT1 gene exon 9 mutations in azoospermia